Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENXBIO Inc. | 210,667 | reported | 01 Feb 2026 | tx 107+1,133,473−303,371 |
| KV PHARMACEUTICAL CO /DE/ | 40,327 | reported | 27 Sept 2013 | tx 7+247,133−80,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Feb 2026 | TAX_WITHHOLDING | REGENXBIO Inc. | 4,700 | 11.16 USD | |
| 06 Jan 2026 | GRANT_AWARD | REGENXBIO Inc. | 73,749 | 0.00 USD | |
| 06 Jan 2026 | GRANT_AWARD | REGENXBIO Inc. | 39,650 | 0.00 USD | deriv |
| 02 Jan 2026 | TAX_WITHHOLDING | REGENXBIO Inc. | 9,793 | 14.40 USD | |
| 01 Aug 2025 | TAX_WITHHOLDING | REGENXBIO Inc. | 4,699 | 8.19 USD | |
| 01 Feb 2025 | TAX_WITHHOLDING | REGENXBIO Inc. | 4,700 | 8.07 USD | |
| 02 Jan 2025 | TAX_WITHHOLDING | REGENXBIO Inc. | 11,395 | 7.73 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENXBIO Inc. | 223,350 | 0.00 USD | deriv |
| 01 Aug 2024 | GRANT_AWARD | REGENXBIO Inc. | 56,446 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | REGENXBIO Inc. | 34,615 | 0.00 USD | |
| 02 Jan 2024 | TAX_WITHHOLDING | REGENXBIO Inc. | 7,893 | 17.95 USD | |
| 02 Jan 2024 | GRANT_AWARD | REGENXBIO Inc. | 54,945 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | REGENXBIO Inc. | 67,940 | 0.00 USD | |
| 03 Jan 2023 | TAX_WITHHOLDING | REGENXBIO Inc. | 1,843 | 22.68 USD | |
| 03 Jan 2023 | GRANT_AWARD | REGENXBIO Inc. | 56,519 | 0.00 USD | deriv |
| 01 Jan 2022 | TAX_WITHHOLDING | REGENXBIO Inc. | 1,332 | 32.70 USD | |
| 03 Jan 2022 | GRANT_AWARD | REGENXBIO Inc. | 7,900 | 0.00 USD | |
| 03 Jan 2022 | GRANT_AWARD | REGENXBIO Inc. | 37,400 | 0.00 USD | deriv |
| 12 Feb 2021 | SALE | REGENXBIO Inc. | 4,701 | 49.08 USD | |
| 12 Feb 2021 | EXERCISE | REGENXBIO Inc. | 4,701 | 12.10 USD | |
| 12 Feb 2021 | EXERCISE | REGENXBIO Inc. | 4,701 | 0.00 USD | deriv |
| 08 Feb 2021 | SALE | REGENXBIO Inc. | 1,300 | 49.11 USD | |
| 08 Feb 2021 | EXERCISE | REGENXBIO Inc. | 1,300 | 12.10 USD | |
| 08 Feb 2021 | EXERCISE | REGENXBIO Inc. | 1,300 | 0.00 USD | deriv |
| 02 Feb 2021 | SALE | REGENXBIO Inc. | 9,500 | 44.77 USD |